Yi Huo

844 total citations
35 papers, 606 citations indexed

About

Yi Huo is a scholar working on Electrical and Electronic Engineering, Automotive Engineering and Molecular Biology. According to data from OpenAlex, Yi Huo has authored 35 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Electrical and Electronic Engineering, 9 papers in Automotive Engineering and 8 papers in Molecular Biology. Recurrent topics in Yi Huo's work include Electric and Hybrid Vehicle Technologies (9 papers), Electric Vehicles and Infrastructure (7 papers) and Advanced Battery Technologies Research (7 papers). Yi Huo is often cited by papers focused on Electric and Hybrid Vehicle Technologies (9 papers), Electric Vehicles and Infrastructure (7 papers) and Advanced Battery Technologies Research (7 papers). Yi Huo collaborates with scholars based in China, Canada and Italy. Yi Huo's co-authors include Angang Yang, Giovanni Belingardi, Pier Giuseppe Anselma, Ali Emadi, Yufang Li, Wenjin Xi, Fan Yang, Xu Chen, Tao Wang and Wei Wang and has published in prestigious journals such as Blood, International Journal of Cancer and Molecular Cancer.

In The Last Decade

Yi Huo

34 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Huo China 15 236 201 192 156 95 35 606
Jufeng Zhang China 18 402 1.7× 290 1.4× 76 0.4× 150 1.0× 122 1.3× 66 871
Travis E. Abbott United States 5 324 1.4× 253 1.3× 54 0.3× 110 0.7× 92 1.0× 6 628
Liang Xian Singapore 13 104 0.4× 62 0.3× 157 0.8× 473 3.0× 29 0.3× 46 741
Mozhdeh Mohammadian Iran 13 169 0.7× 85 0.4× 36 0.2× 87 0.6× 39 0.4× 44 511
Chunjie Xu China 18 372 1.6× 238 1.2× 34 0.2× 64 0.4× 178 1.9× 63 894
Alex Reis Brazil 6 146 0.6× 61 0.3× 23 0.1× 143 0.9× 31 0.3× 22 395
LU Zhen-feng China 9 113 0.5× 58 0.3× 94 0.5× 77 0.5× 52 0.5× 31 336
Eunmi Lee South Korea 12 169 0.7× 66 0.3× 28 0.1× 36 0.2× 182 1.9× 42 759
Mingzhe Wu China 14 116 0.5× 61 0.3× 12 0.1× 330 2.1× 37 0.4× 56 587
Shihao Zhu China 8 108 0.5× 68 0.3× 18 0.1× 30 0.2× 72 0.8× 18 236

Countries citing papers authored by Yi Huo

Since Specialization
Citations

This map shows the geographic impact of Yi Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Huo more than expected).

Fields of papers citing papers by Yi Huo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Huo. The network helps show where Yi Huo may publish in the future.

Co-authorship network of co-authors of Yi Huo

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Huo. A scholar is included among the top collaborators of Yi Huo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Huo. Yi Huo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Zhengyang, Riliang Gu, Yingfeng Zhang, et al.. (2025). TLR7/8 signaling activation enhances the potency of human pluripotent stem cell-derived eosinophils in cancer immunotherapy for solid tumors. Experimental Hematology and Oncology. 14(1). 26–26. 3 indexed citations
2.
Zheng, Wenjing, Yang He, Han Zhang, et al.. (2025). Synergistic innate-adaptive immunity by NKG2D-specific CAR-macrophages drives durable remission in hepatocellular carcinoma. Molecular Cancer. 25(1). 9–9. 1 indexed citations
3.
Li, Mengyu, et al.. (2024). A 62.2dB SNDR Event-Driven Level-Crossing ADC With SAR-Assisted Delay Compensation Loop for Time-Sparse Biomedical Signal Acquisition. IEEE Transactions on Biomedical Circuits and Systems. 19(2). 344–356. 1 indexed citations
4.
Zhang, Han, Yi Huo, Wenjing Zheng, et al.. (2024). Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors. Cellular and Molecular Immunology. 21(11). 1335–1349. 21 indexed citations
5.
Li, Yifan, Yi Huo, Wenjing Zheng, et al.. (2024). Diagnostic and prognostic significance of tetraspanin 6 and its role in facilitating glioma progression. European journal of medical research. 29(1). 522–522. 1 indexed citations
6.
Zhang, Han, Wenjing Zheng, Yi Huo, et al.. (2024). DNAJC1 facilitates glioblastoma progression by promoting extracellular matrix reorganization and macrophage infiltration. Journal of Cancer Research and Clinical Oncology. 150(6). 315–315. 3 indexed citations
7.
Wang, Zexin, et al.. (2024). A 12.9-ENOB 50.6 fJ/conv.step Time-Amplitude Aligned Level-Crossing SAR ADC. 123–127. 1 indexed citations
8.
Huo, Yi, Han Zhang, Wenjing Zheng, et al.. (2023). M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors. Journal of Translational Medicine. 21(1). 225–225. 49 indexed citations
9.
Chen, Xu, Wei Wang, Yufang Li, et al.. (2021). MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling. Journal of Experimental & Clinical Cancer Research. 40(1). 341–341. 14 indexed citations
10.
Huo, Yi, Daniel Lu, Daniel C. Ellwanger, et al.. (2021). Blinatumomab-induced T cell activation at single cell transcriptome resolution. BMC Genomics. 22(1). 145–145. 18 indexed citations
11.
Chen, Xu, Fan Yang, Tianze Zhang, et al.. (2019). MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma. Journal of Experimental & Clinical Cancer Research. 38(1). 99–99. 135 indexed citations
12.
Anselma, Pier Giuseppe, et al.. (2019). Slope-Weighted Energy-Based Rapid Control Analysis for Hybrid Electric Vehicles. IEEE Transactions on Vehicular Technology. 68(5). 4458–4466. 38 indexed citations
13.
Anselma, Pier Giuseppe, et al.. (2018). Mode-shifting Minimization in a Power Management Strategy for Rapid Component Sizing of Multimode Power Split Hybrid Vehicles. SAE technical papers on CD-ROM/SAE technical paper series. 1. 20 indexed citations
14.
Huo, Yi & Fengjun Yan. (2018). A Predictive Energy Management Strategy for Hybrid Electric Powertrain With a Turbocharged Diesel Engine. Journal of Dynamic Systems Measurement and Control. 140(6). 3 indexed citations
15.
Anselma, Pier Giuseppe, et al.. (2018). Real-time rule-based near-optimal control strategy for a single-motor multimode hybrid electric vehicle powertrain. 6 indexed citations
16.
Anselma, Pier Giuseppe, et al.. (2018). Rapid optimal design of a multimode power split hybrid electric vehicle transmission. Proceedings of the Institution of Mechanical Engineers Part D Journal of Automobile Engineering. 233(3). 740–762. 31 indexed citations
17.
Wang, Wei, Gang Ji, Xin Xiao, et al.. (2016). Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1. Oncotarget. 7(42). 68674–68687. 42 indexed citations
18.
Chen, Li, et al.. (2011). Design and Analysis of an Electrical Variable Transmission for a Series–Parallel Hybrid Electric Vehicle. IEEE Transactions on Vehicular Technology. 60(5). 2354–2363. 67 indexed citations
19.
Shi, Yunhui, et al.. (2008). A Novel ROI-Based Rate Control Scheme for H.264. 77–81. 4 indexed citations
20.
Duan, Xingguang, et al.. (2008). Application of on-line inspection probe of machining center in free curve inspecting. 23. 6036–6040. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026